Breast Cancer Trial, Recruiting NCT07498855 Sponsor: Ruijin Hospital Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT07498855
Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have signed and dated a consent form before any trial procedures begin
  • Women aged 18 or older
  • People who have been diagnosed with invasive breast cancer, confirmed through tissue testing
  • People who have had breast-conserving surgery or full breast removal, along with lymph node assessment (either sentinel node biopsy and/or full lymph node removal from the armpit)
  • People who are able to hold their breath for more than 30 seconds after taking a deep breath in
  • People whose treatment plan includes radiation therapy to the lymph node regions, including the internal chest (mammary) nodes, using a deep breath-hold technique
  • People whose treatment plan includes a moderately shortened course of radiation therapy (fewer, slightly larger doses than traditional radiotherapy)
  • People with a general health and functioning score of 80 or above on a standard medical scale (confirm with trial site)
  • People with a life expectancy of more than 5 years
  • People whose surgical wounds have healed sufficiently, with no signs of active infection at the area planned for radiation

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who are pregnant or breastfeeding
  • People with a serious, uncontrolled health condition that the trial doctors believe would make participation unsafe, affect ability to follow the trial plan, or make results harder to interpret
  • People who are unable to understand or follow instructions for breath-hold training
  • People whose breast cancer is on the right side

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 31 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86-021-64370045

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
1 October 2025
Est. completion
31 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Target coverage of the Planning treatment volume (PTV)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov